Ozdemir, N. Et Al. 2014. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study. Cancer Chemotherapy and Pharmacology , vol.74, no.6 , 1139-1147.

Ozdemir, N., Abali, H., Vural, M., YALÇIN, Ş., Oksuzoglu, B., Civelek, B., ... Oguz, D.(2014). Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study. Cancer Chemotherapy and Pharmacology , vol.74, no.6, 1139-1147.

Ozdemir, Nuriye Et Al. "Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study," Cancer Chemotherapy and Pharmacology , vol.74, no.6, 1139-1147, 2014

Ozdemir, Nuriye Et Al. "Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study." Cancer Chemotherapy and Pharmacology , vol.74, no.6, pp.1139-1147, 2014

Ozdemir, N. Et Al. (2014) . "Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study." Cancer Chemotherapy and Pharmacology , vol.74, no.6, pp.1139-1147.

@article{article, author={Nuriye Ozdemir Et Al. }, title={Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study}, journal={Cancer Chemotherapy and Pharmacology}, year=2014, pages={1139-1147} }